<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Churchyard</surname>
    <given-names>G. J.</given-names>
   </name>
   <name>
    <surname>Morgan</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Adams</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Hural</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Graham</surname>
    <given-names>B. S.</given-names>
   </name>
   <name>
    <surname>Moodie</surname>
    <given-names>Z.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2011</year>). 
  <article-title>A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)</article-title>. 
  <source>PLoS ONE</source>
  <volume>6</volume>:
  <fpage>e21225</fpage>. 
  <pub-id pub-id-type="doi">10.1371/journal.pone.0021225</pub-id>
  <?supplied-pmid 21857901?>
  <pub-id pub-id-type="pmid">21857901</pub-id>
 </mixed-citation>
</ref>
